永貴電器(300351.SZ):控股子公司擬向眾合軌道銷售計軸信號系統 銷售額1062萬元
格隆匯3月23日丨永貴電器(300351.SZ)公佈,公司控股子公司北京永列科技有限公司(“北京永列”)近日與浙江浙大網新眾合軌道交通工程有限公司(“眾合軌道”)就“杭州地鐵9號線一期工程信號系統計軸採購項目”簽署《設備採購合同》,根據合同約定北京永列擬向眾合軌道銷售計軸信號系統,銷售額1062萬元(含税)。
浙江永貴電器股份有限公司的控股子公司,長期致力於軌道交通信號系統產品的研發、製造、銷售與服務,是一家專業專注的軌道交通信號系統製造商。北京永列計軸系統產品已通過歐標SIL4級安全認證,並已成功在北京地鐵、武漢地鐵等多條地鐵線路上應用。
上述已簽訂合同的實施預計將對公司2020年度的經營業績產生積極作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.